OptiNose Correlations

OPTN Stock

USD 0.54 0.03 5.88%

The current 90-days correlation between OptiNose and Silver Spike Investment is -0.29 (i.e., Very good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OptiNose moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OptiNose moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

OptiNose Correlation With Market

Average diversification

The correlation between OptiNose and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OptiNose and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.

Moving together with OptiNose Stock

0.75	VALN	Valneva SE ADR	Pair Corr
0.62	FDMT	4D Molecular Therapeutics	Pair Corr
0.83	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.72	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.7	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.7	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.67	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.71	MREO	Mereo BioPharma Group	Pair Corr
0.76	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.71	PEPG	PepGen	Pair Corr
0.64	PIRS	Pieris Pharmaceuticals	Pair Corr
0.68	ABBV	AbbVie Inc	Pair Corr
0.71	ADAP	Adaptimmune Therapeutics	Pair Corr
0.78	AMGN	Amgen Inc	Pair Corr

Moving against OptiNose Stock

0.73	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.64	NAMS	NewAmsterdam Pharma	Pair Corr
0.53	GILD	Gilead Sciences	Pair Corr
0.31	LPCN	Lipocine	Pair Corr
0.69	CDXS	Codexis	Pair Corr
0.61	AVTE	Aerovate Therapeutics	Pair Corr
0.59	VREX	Varex Imaging Corp	Pair Corr
0.57	CRVS	Corvus Pharmaceuticals	Pair Corr
0.56	AGIO	Agios Pharm	Pair Corr
0.52	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.31	ANTX	AN2 Therapeutics	Pair Corr

Related Correlations Analysis

	COLL	PAHC	ANIP	PROC	SSIC	LFCR	KMDA	SHPH	CPIX	IRWD
COLL		-0.58	0.27	0.84	-0.66	-0.87	-0.79	0.43	0.68	0.42	COLL
PAHC	-0.58		-0.14	-0.53	0.28	0.64	0.39	-0.59	-0.59	-0.37	PAHC
ANIP	0.27	-0.14		0.21	-0.14	-0.27	0.15	0.54	0.43	0.61	ANIP
PROC	0.84	-0.53	0.21		-0.72	-0.75	-0.71	0.39	0.66	0.29	PROC
SSIC	-0.66	0.28	-0.14	-0.72		0.6	0.45	-0.39	-0.38	-0.51	SSIC
LFCR	-0.87	0.64	-0.27	-0.75	0.6		0.71	-0.57	-0.74	-0.49	LFCR
KMDA	-0.79	0.39	0.15	-0.71	0.45	0.71		-0.14	-0.48	0.04	KMDA
SHPH	0.43	-0.59	0.54	0.39	-0.39	-0.57	-0.14		0.5	0.63	SHPH
CPIX	0.68	-0.59	0.43	0.66	-0.38	-0.74	-0.48	0.5		0.58	CPIX
IRWD	0.42	-0.37	0.61	0.29	-0.51	-0.49	0.04	0.63	0.58		IRWD
	COLL	PAHC	ANIP	PROC	SSIC	LFCR	KMDA	SHPH	CPIX	IRWD

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PROC	+ 0.84	COLL
KMDA	+ 0.71	LFCR
CPIX	+ 0.68	COLL
CPIX	+ 0.66	PROC
LFCR	+ 0.64	PAHC
IRWD	+ 0.63	SHPH

High negative correlations

LFCR	- 0.87	COLL
KMDA	- 0.79	COLL
LFCR	- 0.75	PROC
CPIX	- 0.74	LFCR
SSIC	- 0.72	PROC
KMDA	- 0.71	PROC

Risk-Adjusted Indicators

There is a big difference between OptiNose Stock performing well and OptiNose Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OptiNose's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
COLL	1.88	(0.43)	0.00	(0.25)	0.00	0.00	3.23	(4.47)	12.29
PAHC	1.82	0.18	0.04	1.10	1.72	(2.08)	3.86	(2.45)	9.05
ANIP	1.90	(0.22)	0.00	(0.06)	0.00	0.00	3.70	(3.75)	10.82
PROC	7.93	0.74	0.11	0.37	7.78	(13.47)	26.19	(13.11)	111.85
SSIC	1.09	0.15	0.03	18.38	1.04	(1.35)	2.89	(1.82)	7.09
LFCR	3.64	0.67	0.13	0.63	4.48	(3.93)	9.76	(5.78)	25.69
KMDA	1.22	0.04	(0.05)	(0.28)	1.60	(1.38)	3.04	(2.82)	7.43
SHPH	5.23	(1.06)	0.00	3.49	0.00	0.00	10.08	(11.66)	50.96
CPIX	2.17	(0.01)	(0.03)	0.09	2.38	(3.03)	4.65	(4.69)	10.64
IRWD	3.41	(0.63)	0.00	(0.15)	0.00	0.00	6.62	(7.54)	20.41

OptiNose Corporate Management

Anthony Krick	Vice Officer	Profile
Michele MBA	VP CFO	Profile
Terence Kohler	Chief Officer	Profile
Paul Spence	Chief Officer	Profile
John Messina	Sr Affairs	Profile
Karen Brophy	Chief Resources	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC